VATS Block for Uniportal Video-assisted Thoracoscopic Surgery
Ultrasound-guided Peripheral Nerve Block for Non-intubated Uniportal Video-assisted Thoracoscopic Surgery
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Traditionally, video-assisted thoracic surgery is performed under general anesthesia with double-lumen endotracheal tube. However, the complications associated with this large tube as well as inhalation anesthetics are frequently reported. Therefore, currently there is a trend toward non-intubated anesthesia methods for video-assisted thoracic surgery, which includes thoracic epidural block, peripheral nerve block, local anesthesia, local combined with peripheral nerve block, etc. Thoracic epidural block demands a high technique, but still risks catastrophic neurological complications in case of accidental dural puncture. Local anesthesia, perhaps more straightforward, however may need supplemental analgesia during incision, which will inevitably interrupt surgery and negatively affect the patients. This study aims to apply ultrasound guidance during local anesthetic injection for local anesthesia-based video assisted thoracic surgery, which helps inject the local anesthetic into the key intercostal nerve plane to provide more specific and precise blockade, thus avoiding the chance of blind injection. At the same time, ultrasound guidance has the potential to reduce the risk of systemic toxicity, prolong the duration of analgesia postoperatively, and facilitates postoperative recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2017
CompletedFirst Posted
Study publicly available on registry
March 17, 2017
CompletedStudy Start
First participant enrolled
March 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2019
CompletedMarch 22, 2017
February 1, 2017
2 years
February 20, 2017
March 20, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Numerical rating scale intraoperatively
Self-reporting pain intensity, pain site, and analgesic dosage during surgery
During chest wall incision
TIme to lose skin sensation (light touch and thermal) over the injection site
Skin sensation will be tested every 5 minutes after ropivacaine injection until loss of both sensation (readiness for skin incision)
Up to 30 mins after ropivacaine injection
Secondary Outcomes (3)
Ropivacaine concentration at different time points after injection
Up to 120 mins following injection
Common characteristics of ultrasound anatomy by analyzing video clips
Three time points (upon obtaining informed consent, prior to injection and during injection)
Numerical rating scale postoperatively
Up to 72 hours following surgery
Study Arms (1)
VATS block (ropivacaine + epinephrine)
EXPERIMENTALVATS block is the peripheral nerve block for video-assisted thoracic surgery, whose injection is administered at the site of chest wall incision.
Interventions
VATS is the abbreviation of video-assisted thoracic surgery, which aims to minimize the wound for thoracic surgery and to enhance patient recovery after surgery
30 mL 0.5% ropivacaine is used to achieve VATS block
1:400000 epinephrine is mixed with ropivacaine (local anesthetic) to reduce the risk of local anesthetic systemic toxicity
Eligibility Criteria
You may qualify if:
- Adults younger than 80 years old and weighing between 50-90 kg are scheduled for one-port video assisted thoracic surgery .
You may not qualify if:
- Anticipated difficult airway
- Obvious coagulation abnormality
- Psychiatric patients or drug addiction
- Emergency operation or patients with a full stomach
- Difficulty in language expression
- Allergic to local anesthetic, morphine, or NSAID
- BMI \> 35
- Pregnancy
- Respiratory insufficiency
- Severe pleural adhesion
- Need for pleurodesis
- Refuse patient-controlled analgesia
- Patients with a pacemaker
- Severe liver dysfunction (serum albumin\<25g/l or Child-Pugh score≧10)
- Severe kidney dysfunction (creatinine clearance\<30ml/min)
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2017
First Posted
March 17, 2017
Study Start
March 27, 2017
Primary Completion
March 26, 2019
Study Completion
March 26, 2019
Last Updated
March 22, 2017
Record last verified: 2017-02